Figure 1

Gal-3 is overexpressed in BECs and level of Gal-3 is increased in the serum PBC patients.
(A) Immunohistochemistry of Gal-3 in liver pathology a) PBC, b) viral hepatitis B, c), viral hepatitis C, d) sclerosing cholangitis (Gal-3 expression in BECs, black arrows; no Gal-3 expression in sclerosing bile ducts, red arrows). (B) Serum level of Gal-3 determined in eleven patients irrespectively of histological stage of disease and eleven healthy age and sex matched controls. Data were analyzed by Student t test and presented as mean + SE, or sccater plot *p < 0.05.